In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aegerion Pharmaceuticals Inc.

Division of Novelion Therapeutics Inc.
www.aegerion.com

Latest From Aegerion Pharmaceuticals Inc.

ICER Chief Scientific Officer Bradt Brings Pharma Perspective

Pamela Brandt joins health technology assessment group after stints at Aegerion, Astellas and Abbott Labs.

Policy Market Access

Amgen, Astellas Bring Tally Of US Charity Co-Pay Kickback Settlements To Eight

Astellas to pay $100m and Amgen to pay $24.75m to resolve allegations they paid Medicare copays for their products through copay assistance foundations.

Legal Issues Enforcement

Patient Assistance Charity Programs Restricted Under Jazz, Lundbeck Settlements

Jazz, Lundbeck and Alexion settle DoJ allegations they paid kickbacks through co-pay assistance foundations, but only two of them enter corporate integrity agreements.
Legal Issues Medicare

Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma

Already having launched several portfolio companies, Roivant goes a step further by spinning out CNS specialist Arvelle from Axovant. BI and IBM will incorporate blockchain technology in clinical trials, while AbbVie licenses multiple myeloma candidate from TeneoBio.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Novelion Therapeutics Inc.
  • Senior Management
  • Mary Szela, CEO
    Gregory D Perry, CFO
    Remi A Menes, Chief Commercial Officer
  • Contact Info
  • Aegerion Pharmaceuticals Inc.
    Phone: (855) 305-2347
    One Main St., Ste. 800
    Cambridge, MA 02142
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register